Antidepressants: Psychiatrists' opinions and clinical practice

Acta Psychiatrica Scandinavica

Volumn 108, Issue 1, 2003, Pages 24-31

  Depont, F ^a   Rambelomanana, S ^a   Le Puil, S ^a   Begaud, B ^a   Verdoux, H ^a   Moore, N ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Antidepressive agents; Depression; Depressive disorder; Drug; Physician's practice patterns; Prescriptions; Treatment outcome

Indexed keywords

AMINEPTINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; FLUOXETINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MOCLOBEMIDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; CLINICAL PRACTICE; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; FRACTIONATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SCHOOL CHILD;

EID: 0037789290     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.00088.x     Document Type: Article

References (33)

1. DENIG P, HAAIJER-RUSKAMP FM, WESSELING H, VERSLUIS A. Impact of clinical trials on the adoption of new drugs within a university hospital. Eur J Clin Pharmacol 1991;41:325-328.
2. DENIG P, HAAIJER-RUSKAMP FM, ZUSLING DH. How physicians choose drugs. Soc Sci Med 1988;27:1381-1386.
3. CHREN MM, LANDEFELD CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary [see comments]. JAMA 1994;271:684-689.
4. GILL PS, FREEMANTLE N, BERO L, HAAIJER-RUSKAMP F, MARKELA M, BARJESTEH KP. GPs' prescribing behaviour may be affected by drug promotion (letter). BMJ 1996;313:367.
5. ISACSSON G, BERGMAN U, WASSERMAN D, REDFORS I, SJOQVIST F. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 1996;8:153-160.
6. BARBUI C, HOTOPF M. Forty years of antidepressant drug trials. Acta Psychiatr Scand 2001;104:92-95.
7. NAYLOR CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995;345:840-842.
8. GEDDES JR, FREEMANTLE N, MASON J, ECCLES MP, BOYNTON J. SSRI for depression. (Cochrane review) In: the Cochrane Library, issue 1, 2003. Oxford: Update Software.
9. MIETTINEN O. Simple interval-estimation of risk ratio. Am J Epidemiol 1974;100:515-516.
10. Répertoire ADELI. DRASS Aquitaine. Bordeaux: Drassaquitaine, 1999.
11. SCHUCK S, ALLAIN H, LEBEUX P, CHAPERON J. Prescriptions for antidepressants in a population of psychiatrists and non-psychiatrists. Presse Med 2000;29:357-362.
12. Observatoire National des Prescriptions et Consommations des Médicaments. Etude de la prescription et de la consommation des antidépresseurs en ambulatoire (http://agmed.sante.gouv.fr/fr/htm/5/5000.htm). Paris: Agence du médicament, 1998.
13. ANTHONY JC, PETRONIS KR. Suspected risk factors for depression among adults 18-44 years old. Epidemiology 1991;2:123-132.
14. ROBINS L, REGIER D. Psychiatric disorders in America: the epidemiologic catchment area study. New York: Free Press, 1991.
15. ROUILLON F, BLACHIER C, DREYFUS JP, BOUHASSIRA M, ALLICAR MP. Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population. Encephale 1996;22:39-48.
16. WEISSMAN MM, BLAND RC, CANINO GJ et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-299.
17. PARKER G, HADZI-PAVLOVIC D. Is any female preponderance in depression secondary to a primary female preponderance in anxiety disorders? Acta Psychiatr Scand 2001;103:252-256.
18. EGBERTS AC, VEENSTRA M, DE JONG-VAN DEN BERG LT. Antidepressant drug choice for first users in two regions in The Netherlands. Pharm World Sci 1999;21:132-136.
19. MACKAY FR, DUNN NR, MARTIN RM, PEARCE GL, FREEMANTLE SN, MANN RD. Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract 1999;49:892-896.
20. SIMON GE, VONKORFF M, HEILIGENSTEIN JH et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897-1902.
21. ANDERSON IM, TOMENSON BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995;310:1433-1438.
22. SONG F, FREEMANTLE N, SHELDON TA et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993;306:683-687.
23. ANDRADE SE, WALKER AM, GOTTLIEB LK et al. Discontinuation of antihyperlipidemic drugs - do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995;332:1125-1131.
24. CONCATO J, SHAH N, HORWITZ RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
25. BENSON K, HARTZ AJ. A comparison of observational studies and randomized, controlled trials. Am J Ophthalmol 2000;130:688.
26. ARMSTRONG D, REYBURN H, JONES R. A study of general practitioners' reasons for changing their prescribing behaviour. BMJ 1996;312:949-952.
27. PATRIS M, BOUCHARD JM, BOUGEROL T et al. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacol 1996;11:129-136.
28. CHOUINARD G, SAXENA B, BELANGER MC et al. A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord 1999;54:39-48.
29. KASPER S, FUGER J, MOLLER HJ. Comparative efficacy of antidepressants. Drugs 1992;43(suppl. 2):11-22.
30. MARTIN RM, HILTON SR, KERRY SM, RICHARDS NM. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants (see comments). BMJ 1997;314:646-651.
31. OWENS D. New or old antidepressants? Benefits of new drugs are exaggerated. BMJ 1994;309:1281-1282.
32. DONOGHUE JM, TYLEE A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996;168:164-168.
33. MAMDANI MM, PARIKH SV, AUSTIN PC, UPSHUR RE. Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry 2000;157:360-367.